SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 52 filers reported holding SPRING BK PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $0 | – | 55 | -45.0% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 100 | -99.8% | 0.00% | – |
Q2 2019 | $161,000 | -12.0% | 44,100 | +152.0% | 0.00% | – |
Q1 2019 | $183,000 | -2.1% | 17,502 | -3.5% | 0.00% | – |
Q4 2018 | $187,000 | -74.6% | 18,136 | -70.4% | 0.00% | – |
Q3 2018 | $736,000 | +59.7% | 61,242 | +57.0% | 0.00% | – |
Q2 2018 | $461,000 | +3741.7% | 39,005 | +4775.6% | 0.00% | – |
Q1 2018 | $12,000 | -88.0% | 800 | -89.3% | 0.00% | – |
Q4 2017 | $100,000 | -80.9% | 7,500 | -75.9% | 0.00% | – |
Q3 2017 | $523,000 | +80.3% | 31,100 | +45.1% | 0.00% | – |
Q2 2017 | $290,000 | – | 21,435 | +21335.0% | 0.00% | – |
Q1 2017 | $0 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PARSONS CAPITAL MANAGEMENT INC/RI | 195,165 | $1,559,000 | 0.21% |
DAFNA Capital Management LLC | 27,412 | $219,000 | 0.19% |
Verity & Verity, LLC | 12,385 | $99,000 | 0.03% |
Baker Brothers Advisors | 219,298 | $1,752,000 | 0.02% |
Alyeska Investment Group, L.P. | 200,000 | $1,598,000 | 0.01% |
Alyeska Investment Group, L.P. | 200,000 | $1,598,000 | 0.01% |
SILVERCREST ASSET MANAGEMENT GROUP LLC | 97,286 | $777,000 | 0.01% |
BRYN MAWR TRUST Co | 14,000 | $112,000 | 0.01% |
BlackRock Investment Management, LLC | 163 | $1,000 | 0.00% |
MORGAN STANLEY | 12,500 | $100,000 | 0.00% |